Status:
UNKNOWN
Quality of Life in Patients With Short Bowel Syndrome Treated Without and With Teduglutide - a Prospective Nested Matched Pair Analysis
Lead Sponsor:
Charite University, Berlin, Germany
Collaborating Sponsors:
Takeda
Conditions:
Short Bowel Syndrome
Intestinal Failure
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this prospective longitudinal study is to compare the quality of life of short bowel patients prior to and on teduglutide treatment with a non-treated patient group in a matched-pair design...
Detailed Description
Short bowel syndrome (SBS) is a malabsorptive disorder mostly caused by surgical interventions, which may result in chronic intestinal failure (cIF). The incidence is progressively increasing due to m...
Eligibility Criteria
Inclusion
- SBS-associated adult chronic IF with parenteral nutritional support
- previous inclusion in the PNLiver trial with existing SF-36 and SBSQoL data
- signed informed consent
Exclusion
- teduglutide stop before study initiation
- refusal or withdrawal of consent
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04733066
Start Date
September 1 2020
End Date
September 1 2022
Last Update
February 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charite University, Berlin, Germany
Berlin, Germany, 10117